WO2005123131A3 - High pressure spray-dry of bioactive materials - Google Patents
High pressure spray-dry of bioactive materials Download PDFInfo
- Publication number
- WO2005123131A3 WO2005123131A3 PCT/US2005/020792 US2005020792W WO2005123131A3 WO 2005123131 A3 WO2005123131 A3 WO 2005123131A3 US 2005020792 W US2005020792 W US 2005020792W WO 2005123131 A3 WO2005123131 A3 WO 2005123131A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bioactive materials
- high pressure
- dry
- pressure spray
- powder particles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002564791A CA2564791A1 (en) | 2004-06-14 | 2005-06-13 | High pressure spray-dry of bioactive materials |
EP05770439A EP1755677A4 (en) | 2004-06-14 | 2005-06-13 | High pressure spray-dry of bioactive materials |
AU2005254062A AU2005254062B2 (en) | 2002-04-11 | 2005-06-13 | High pressure spray-dry of bioactive materials |
JP2007527797A JP2008505192A (en) | 2004-06-14 | 2005-06-13 | High pressure spray drying of bioactive materials |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57985004P | 2004-06-14 | 2004-06-14 | |
US60/579,850 | 2004-06-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005123131A2 WO2005123131A2 (en) | 2005-12-29 |
WO2005123131A3 true WO2005123131A3 (en) | 2008-01-03 |
Family
ID=35510270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/020792 WO2005123131A2 (en) | 2002-04-11 | 2005-06-13 | High pressure spray-dry of bioactive materials |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1755677A4 (en) |
JP (1) | JP2008505192A (en) |
AU (1) | AU2005254062B2 (en) |
CA (1) | CA2564791A1 (en) |
WO (1) | WO2005123131A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9115357B2 (en) | 2004-05-12 | 2015-08-25 | Baxter International Inc. | Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes |
US9339465B2 (en) | 2004-05-12 | 2016-05-17 | Baxter International, Inc. | Nucleic acid microspheres, production and delivery thereof |
US9592297B2 (en) | 2012-08-31 | 2017-03-14 | Bayer Healthcare Llc | Antibody and protein formulations |
CN105555376B (en) * | 2013-03-28 | 2017-05-17 | 英斯迪罗有限公司 | Apparatus and method for producing dispersions and solids |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1834651A1 (en) * | 2006-03-15 | 2007-09-19 | Universiteit Gent | Compositions and methods for veterinary vaccination |
US8268354B2 (en) * | 2007-11-07 | 2012-09-18 | Aridis Pharmaceuticals | Sonic low pressure spray drying |
CA2738621C (en) | 2008-10-02 | 2017-01-31 | Pharmathene Inc. | Anthrax vaccine formulation and uses thereof |
CN105770882A (en) | 2009-05-20 | 2016-07-20 | Aeras全球Tb疫苗基金会 | Stable, spray dried, immunogenic, viral compositions |
EP3216462A3 (en) | 2010-02-26 | 2017-12-20 | Novo Nordisk A/S | Stable antibody containing compositions |
NZ702494A (en) | 2010-03-01 | 2016-09-30 | Bayer Healthcare Llc | Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
WO2011147921A1 (en) | 2010-05-28 | 2011-12-01 | Novo Nordisk A/S | Stable multi-dose compositions comprising an antibody and a preservative |
EP2691415B1 (en) * | 2011-03-28 | 2018-07-11 | Ablynx N.V. | Method for producing solid formulations comprising immunoglobulin single variable domains |
ITMI20112042A1 (en) * | 2011-11-10 | 2013-05-11 | Eratech S R L | POWDER TO RECONSTITUTE BEFORE INCLUDING MELATONIN AND INJECTABLE PREPARATION OBTAINABLE FROM SUCH POWDER. |
EP3532500A1 (en) * | 2016-10-31 | 2019-09-04 | Vectura Limited | Inhalable powder composition comprising il-13 antibody |
EP3459529A1 (en) * | 2017-09-20 | 2019-03-27 | Tillotts Pharma Ag | Preparation of sustained release solid dosage forms comprising antibodies by spray drying |
GB201718888D0 (en) * | 2017-11-15 | 2017-12-27 | Ucb Biopharma Sprl | Method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040042972A1 (en) * | 2002-04-11 | 2004-03-04 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for intranasal administration |
US20040042971A1 (en) * | 2002-04-11 | 2004-03-04 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for pulmonary administration |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0913177A1 (en) * | 1997-11-03 | 1999-05-06 | Roche Diagnostics GmbH | Process for producing dry, amorphous products comprising biological active materials by means of convection drying technique, especially spray drying |
US6531580B1 (en) * | 1999-06-24 | 2003-03-11 | Ixsys, Inc. | Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same |
US6855493B2 (en) * | 2000-11-28 | 2005-02-15 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
JP2006512102A (en) * | 2002-04-11 | 2006-04-13 | メディミューン・ヴァクシンズ・インコーポレーテッド | Preservation of bioactive materials by spray drying |
WO2004058156A2 (en) * | 2002-12-17 | 2004-07-15 | Medimmune Vaccines, Inc. | High pressure spray-dry of bioactive materials |
-
2005
- 2005-06-13 AU AU2005254062A patent/AU2005254062B2/en not_active Ceased
- 2005-06-13 EP EP05770439A patent/EP1755677A4/en not_active Withdrawn
- 2005-06-13 CA CA002564791A patent/CA2564791A1/en not_active Abandoned
- 2005-06-13 JP JP2007527797A patent/JP2008505192A/en active Pending
- 2005-06-13 WO PCT/US2005/020792 patent/WO2005123131A2/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040042972A1 (en) * | 2002-04-11 | 2004-03-04 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for intranasal administration |
US20040042971A1 (en) * | 2002-04-11 | 2004-03-04 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for pulmonary administration |
Non-Patent Citations (1)
Title |
---|
See also references of EP1755677A4 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9115357B2 (en) | 2004-05-12 | 2015-08-25 | Baxter International Inc. | Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes |
US9339465B2 (en) | 2004-05-12 | 2016-05-17 | Baxter International, Inc. | Nucleic acid microspheres, production and delivery thereof |
US9592297B2 (en) | 2012-08-31 | 2017-03-14 | Bayer Healthcare Llc | Antibody and protein formulations |
CN105555376B (en) * | 2013-03-28 | 2017-05-17 | 英斯迪罗有限公司 | Apparatus and method for producing dispersions and solids |
Also Published As
Publication number | Publication date |
---|---|
CA2564791A1 (en) | 2005-12-29 |
AU2005254062A1 (en) | 2005-12-29 |
AU2005254062B2 (en) | 2011-02-17 |
WO2005123131A2 (en) | 2005-12-29 |
JP2008505192A (en) | 2008-02-21 |
EP1755677A2 (en) | 2007-02-28 |
EP1755677A4 (en) | 2009-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005123131A3 (en) | High pressure spray-dry of bioactive materials | |
WO2004058156A3 (en) | High pressure spray-dry of bioactive materials | |
WO2008030968A3 (en) | Fusion peptide therapeutic compositions | |
WO2006051110A3 (en) | Stable formulations of insulinoptropic peptides | |
WO2003087335A3 (en) | Preservation of bioactive materials by spray drying | |
WO2006051103A3 (en) | Stable formulations of peptides | |
WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
EP2269631A3 (en) | Pharmaceutical compositions comprising botulinum neurotoxin for use in medicine and cosmetics | |
AU2003222137A1 (en) | Microgel particles for the delivery of bioactive materials | |
WO2007043048A3 (en) | Self-assembled fmoc-ff hydrogels | |
WO2003087339A3 (en) | Spray freeze dry of compositions for pulmonary administration | |
WO2006026760A3 (en) | 1-amino imidazo-containing compounds and methods | |
WO2008031556A3 (en) | 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions | |
WO2004093795A3 (en) | Compositions for delivery of drug combinations | |
WO2004110352A3 (en) | Compounds having activity in increasing ion transport by mutant-cftr and uses thereof | |
NO20073059L (en) | 2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | |
WO2007016388A3 (en) | Liquid formulations for controlled delivery of benzisoxazole derivatives | |
WO2005009393A3 (en) | Stable radiopharmaceutical compositions and methods for preparation | |
ATE509634T1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING INCRETIN PEPTIDE AND APROTIC-POLAR SOLVENT | |
ZA200708304B (en) | Dipeptidyl Peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent | |
WO2010030670A3 (en) | Compositions and methods for the prevention of oxidative degradation of proteins | |
AU2003218759A1 (en) | Stabilization of resorcinol derivatives in cosmetic compositions | |
HK1058902A1 (en) | Compositions for protein delivery via the pulmonary route | |
MY149306A (en) | Solid preparation containing an insulin sensitizer | |
WO2007025988A3 (en) | Liquid formulations of pegylated growth hormone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2564791 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005254062 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005770439 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2005254062 Country of ref document: AU Date of ref document: 20050613 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005254062 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007527797 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2005770439 Country of ref document: EP |